WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke NAXIO wurde als Wortmarke am 21.09.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1645571 |
| Länder | 
|
| Basismarke |
Nr. 90592998,
22. März 2021
|
| Anmeldedatum | 21. September 2021 |
| Ablaufdatum | 21. September 2031 |
Markeninhaber
180 Canal St. 3rd Flr.
Boston MA 02114
US
Boston MA 02114
US
Markenvertreter
2400 Ansys Drive, Suite 102
Canonsburg PA 15317
US
Waren und Dienstleistungen
05
Pharmaceutical products for the treatment of cancer or
infectious diseases, namely, genetically engineered
hematopoietic cells for the treatment of cancer or
infectious diseases; pharmaceutical preparations for cell
therapy, namely, genetically engineered hematopoietic cells
for the treatment of cancer or infectious diseases;
biological preparations for cancer therapies and
anti-infective therapies, namely, chimeric antigen receptors
(CAR) and therapeutic preparations thereof, namely, viral
vectors and plasmid vectors expressing CAR genes;
therapeutic antibodies for use as immunotherapeutic agents
for the treatment of cancer and infectious diseases;
therapeutic T-cell receptors for use as immunotherapeutic
agents for the treatment of cancer and infectious diseases;
preparations for genetically modifying human or animal cells
for medical purposes, including viral vectors and plasmid
vectors
42
Industrial and scientific analysis in the field of
pharmaceuticals and biotechnology, namely, in the field of
genetically engineered hematopoietic cells, cell therapies,
chimeric antigen receptors (CAR), therapeutic antibodies,
therapeutic T-cell receptors, viral vectors and plasmid
vectors; scientific research services in the field of
pharmaceuticals and biotechnology, namely, genetically
modifying human or animal cells to enable cells to be used
for therapeutic purposes; scientific research in the
development of cancer therapies or anti-infective therapies,
namely, in the development of genetically engineered
hematopoietic cells, cell therapies, chimeric antigen
receptors (CAR), therapeutic antibodies, therapeutic T-cell
receptors and viral vectors and plasmid vectors
44
Medical services in the field of extraction of human
hematopoietic cells from patients and in the field of
genetically modifying hematopoietic cells for therapeutic
purposes; providing medical and therapy advice and
consultancy in the field of medical therapies, namely, in
the field of genetically engineered hematopoietic cells,
cellular therapies, antibody therapies, and T-cell receptor
therapies for the treatment of cancer or infectious
diseases; providing information regarding the treatment of
cancer and infectious diseases by means of a website,
namely, in the field of treatment of cancer and infectious
diseases by genetically engineered hematopoietic cells,
cellular therapies, antibody therapies, and T-cell receptor
therapies
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 05. Juni 2023 | 2023/23 Gaz | KR | Ablehnung |
| 28. Dezember 2022 | 2022/52 Gaz | CH | Ablehnung |
| 24. November 2022 | 2022/47 Gaz | JP | Ablehnung |
| 24. August 2022 | 2022/34 Gaz | CN | Ablehnung |
| 27. Juli 2022 | 2022/30 Gaz | GB | Ablehnung |
| 06. Juli 2022 | 2022/27 Gaz | EM | Ablehnung |
| 01. Juni 2022 | 2022/22 Gaz | AU | Ablehnung |
| 21. September 2021 | 2022/5 Gaz | US | Eintragung |
ID: 141645571